Immunic, Inc.
IMUX
$1.12
-$0.03-2.61%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -100.51M | -96.90M | -95.31M | -97.92M | -93.61M |
| Total Depreciation and Amortization | 134.00K | 122.00K | 114.00K | 105.00K | 111.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 15.04M | 14.39M | 14.15M | 14.71M | 7.63M |
| Change in Net Operating Assets | 564.00K | 6.57M | 8.70M | 7.83M | 15.05M |
| Cash from Operations | -84.77M | -75.83M | -72.34M | -75.28M | -70.83M |
| Capital Expenditure | -264.00K | -426.00K | -420.00K | -261.00K | -334.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | 0.00 | 0.00 | 4.36M | 9.80M |
| Cash from Investing | -264.00K | -426.00K | -420.00K | 4.10M | 9.46M |
| Total Debt Issued | 74.27M | 74.27M | 74.27M | 74.27M | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 274.00K | 795.00K | 1.08M | 1.17M | 1.03M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -6.00K | -- | -- | -- | -- |
| Cash from Financing | 74.54M | 75.07M | 75.35M | 75.45M | 1.03M |
| Foreign Exchange rate Adjustments | -517.00K | 570.00K | -187.00K | 293.00K | 262.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -11.01M | -618.00K | 2.40M | 4.55M | -60.07M |